人工智能与肺癌筛查的整合:在公共卫生环境中开发人工智能的考量
肺癌筛查的推广使老年吸烟人群胸部影像检查增加,筛查病例中可检出CT可测的肺气肿或冠状动脉钙化升高。本文讨论在公共卫生环境下开发用于胸部CT筛查的人工智能工具时,如何平衡各方需求,并介绍AGILEDxRx联盟致力于促进广泛、公平实施高质量胸部CT筛查。
要点
- 肺癌筛查成功关键在于对3mm至15mm非钙化肺结节进行特征描述和测量变化。
- 筛查中可检出CT可测的肺气肿或冠状动脉钙化升高,提示冠状动脉疾病存在。
- 基于这些额外发现的早期干预正在出现并遵循既定方案。
核心结论
- 鉴于诊断创新速度和潜在公共卫生影响,现在应审视开发有用胸部CT筛查基础设施的问题,因为胸部CT筛查将很快涉及全球数百万参与者。
- 一个主要关注点是如何平衡致力于构建精确、可重复且经济的人工智能工具的各方多样化需求,同时满足接受该服务的筛查参与者的公共卫生需求。
- AGILEDxRx联盟致力于以可及成本促进广泛、公平实施使用先进计算工具的多学科高质量胸部CT筛查。
研究设计与样本
- 本文为综述,讨论人工智能与肺癌筛查整合中在公共卫生环境下开发人工智能的考量。
主要发现
- 肺癌筛查的实施导致老年、吸烟暴露人群的胸部影像检查扩大。
- 越来越多的筛查病例被发现具有CT可测的肺气肿或冠状动脉钙化水平升高,提示冠状动脉疾病的存在。
- 基于这些额外发现(尤其是冠状动脉钙化)的早期干预正在出现,并遵循既定方案。
- 肺癌筛查成功是因为它通过特征描述和测量直径3mm至15mm非钙化肺结节的变化来检测可治愈的早期原发性肺癌。
- 对影像学方法的密切关注对肺癌筛查成功至关重要,可靠的早期肺气肿和冠状动脉疾病定量特征描述需要类似的图像质量问题。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lung cancer screening implementation has led to expanded imaging of the chest in older, tobacco-exposed populations. Growing numbers of screening cases are also found to have CT-detectable emphysema or elevated levels of coronary calcium, indicating the presence of coronary artery disease. Early interventions based on these additional findings, especially with coronary calcium, are emerging and follow established protocols. Given the pace of diagnostic innovation and the potential public health impact, it is timely to review issues in developing useful chest CT screening infrastructure as chest CT screening will soon involve millions of participants worldwide. Lung cancer screening succeeds because it detects curable, early primary lung cancer by characterizing and measuring changes in non-calcified, lung nodules in the size-range from 3mm to 15 mm in diameter. Therefore, close attention to imaging methodology is essential to lung screening success and similar image quality issues are required for reliable quantitative characterization of early emphysema and coronary artery disease. Today's emergence of advanced image analysis using artificial intelligence (AI) is disrupting many aspects of medical imaging including chest CT screening. Given these emerging technological and volume trends, a major concern is how to balance the diverse needs of parties committed to building AI tools for precise, reproducible, and economical chest CT screening, while addressing the public health needs of screening participants receiving this service. A new consortium, the Alliance for Global Implementation of Lung and Cardiac Early Disease Detection and Treatment (AGILEDxRx) is committed to facilitate broad, equitable implementation of multi-disciplinary, high quality chest CT screening using advanced computational tools at accessible cost.
引用
- Mulshine JL, Avila RS, Silva M, et al. AI integrations with lung cancer screening: Considerations in developing AI in a public health setting. Eur J Cancer. 2025. PMID: 40090215. doi:10.1016/j.ejca.2025.115345
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。